Related by context. All words. (Click for frequent words.) 76 oral prodrug 76 PDE4 inhibitor 76 mertansine 76 targeted radiotherapeutic 75 factor VIIa 75 investigational humanized monoclonal antibody 75 HQK 75 reslizumab 74 Phase IIb clinical trials 74 Archexin 74 orally administered inhibitor 74 novel peptide 74 Personalized Immunotherapy 74 JAK inhibitor 74 volociximab 74 Panzem R 73 histone deacetylase HDAC inhibitor 73 Thrombin 73 immunotherapeutic vaccine 73 pan HDAC inhibitor 73 Squalamine 73 depsipeptide 73 JAK2 inhibitor 73 beta 1a 73 INS# [001] 73 PNP inhibitor 73 FVIIa 73 Onconase 73 humanized monoclonal 73 Mipomersen 73 Fc fusion protein 73 molecular imaging radiopharmaceutical 73 therapeutic monoclonal antibody 73 small molecule activators 73 PRT# 73 liposomal formulation 73 AEG# 72 Liposomal 72 peripherally acting 72 receptor tyrosine kinase inhibitor 72 XL# XL# 72 THR beta agonist 72 Lixivaptan 72 ADP receptor antagonist 72 proteasome inhibitor 72 gefitinib Iressa 72 Xanafide 72 IV Busulfex 72 IMA# 72 Panzem 72 thalidomide Thalomid 72 TKM ApoB 72 targeted antifolate 72 Angiocept 72 ENMD # 72 recombinant factor VIIa 72 Degarelix 72 Dasatinib 72 histone deacetylase inhibitor 72 selective adenosine 72 Nanobody 72 Hsp# Inhibitor 72 EP #R 72 TRO# 72 rxRNA 72 Immunotherapeutic 72 GW# [003] 72 Ecallantide 72 PEGylated interferon 72 nucleoside analog 71 Zemiva TM 71 CCX# 71 Curaxin 71 isoform selective 71 alkylating agent 71 selective inhibition 71 RhuDex ® 71 selective modulator 71 selective antagonist 71 OvaRex R 71 anti CD3 71 Initiates Clinical 71 selective androgen receptor modulator 71 NPC 1C 71 Factor IX 71 Cloretazine ® 71 intranasal formulation 71 Aurora Kinase 71 tiapamil 71 antifibrotic 71 antisense inhibitors 71 GRN# 71 Daclizumab 71 Dalbavancin 71 IAP inhibitors 71 Aflibercept 71 Granulocyte Colony Stimulating Factor 71 cathepsin K inhibitor 71 CD# monoclonal antibody 71 somatostatin analogue 71 Proxinium TM 71 Aliskiren 71 angiogenesis inhibitor 71 Tesetaxel 71 Aviptadil 71 immune modulator 71 UPLYSO 71 Inhalation Solution 71 protein tyrosine phosphatase 1B 71 TBC# 71 IAP inhibitor 71 vidofludimus 71 hypoxia activated prodrug 71 kidney urologic 71 small molecule tyrosine 71 metaglidasen 71 NV1FGF 71 HuMax TAC 71 elotuzumab 71 Civacir 71 RECOTHROM R 71 Pathway Inhibitor 71 Fenretinide 71 non nucleoside inhibitor 71 DCVax R 71 Interferon alpha 71 nicotinic alpha 7 71 forodesine 71 Kinase Inhibitor 71 PEGylated 71 antibody MAb 71 Ocrelizumab 71 humanized anti 71 MKC# MKC# PP 70 glatiramer 70 romidepsin novel 70 Preclinical studies suggest 70 Marqibo TM 70 diarrhea predominant irritable 70 Androxal TM 70 GVAX ® 70 mGluR2 NAM 70 acetonide FA 70 Enzastaurin 70 NTDDS 70 Nanobody ® 70 Pimavanserin 70 CYT# potent vascular disrupting 70 pharmacological chaperone 70 Maxy G# 70 Panzem R NCD 70 aurora kinase 70 dasatinib Sprycel 70 HDL Selective Delipidation 70 orally bioavailable 70 novel VDA molecule 70 RNAi therapeutic targeting 70 M# rationally 70 Presents Preclinical Data 70 huC# DM4 70 MTP inhibitor 70 Orally administered 70 cancer immunotherapies 70 siRNA therapeutic 70 Myocet 70 DXL# 70 HepDirect prodrug 70 Guanilib 70 fosbretabulin 70 non nucleoside HCV 70 SERMs 70 multi kinase inhibitor 70 XmAb 70 Maribavir 70 vivo validation 70 antisense inhibitor 70 novel histone deacetylase 70 histone deacetylase HDAC 70 MAGE A3 ASCI 70 cannabinor 70 IL# PE#QQR 70 Meets Primary Endpoint 70 ATL# [002] 70 A1PI 70 PEGylated Fab fragment 70 Azedra TM 70 tranilast 70 GMX# 70 Cloretazine 70 targeting CD# 70 Achieves Primary Endpoint 70 Resten NG 70 Solazed TM 70 MKC# MT 70 Initiate Clinical Trial 70 humanized antibody 70 sargramostim 70 ALN PCS 70 Radezolid 70 preclinical efficacy 70 Interferon Beta 70 sitaxsentan 70 Cleviprex TM clevidipine 70 Factor Xa inhibitor 70 generation purine nucleoside 70 PDE# inhibitors 70 Interferon beta 70 IMiD 70 Omacetaxine 70 BrachySil TM 70 Micromet BiTE 70 YONDELIS 70 Anidulafungin 70 cetuximab Erbitux R 70 Annamycin 70 polymerase inhibitor 70 Factor VEGF 70 vinorelbine tartrate 70 HuLuc# 70 Dapagliflozin 70 JAK1 70 immune modulating 70 CTAP# Capsules 70 vascular disrupting agents 70 ELACYT 70 XYOTAX TM 70 epothilones 70 ocular formulation 70 PDX pralatrexate 70 OMP #R# 70 polyclonal antibody 70 Epratuzumab 70 humanized monoclonal antibodies 70 HSP# inhibitor 70 Oncaspar 70 radiation sensitizer 69 MEK inhibitors 69 TLR9 agonist 69 rhFVIIa 69 anti CD3 monoclonal 69 PEG SN# 69 CYC# 69 Lpathomab 69 OncoVex 69 CDK inhibitor 69 SYN# 69 HDAC Inhibitor 69 p# inhibitor 69 HuMax EGFr 69 Trofex 69 vapreotide acetate 69 trastuzumab DM1 T DM1 69 Xyfid TM 69 Safinamide 69 JAK3 69 Phase #b/#a clinical 69 JUVISTA R Human 69 anti secretory 69 JAK inhibitors 69 MEK inhibitor 69 etanercept Enbrel 69 ATL# [001] 69 Janus Kinase 69 KL4 Surfactant 69 pegylated 69 lexidronam injection 69 Neulasta ® 69 recombinant enzyme 69 Panzem NCD 69 including eniluracil ADH 69 NS#/#A protease 69 cMET 69 corticosteroid dexamethasone 69 plasma kallikrein inhibitor 69 Sudhir Agrawal D.Phil 69 HCV protease 69 IRX 2 69 Octreotide 69 diagnostic biomarker 69 ESBA# 69 phase IIb clinical 69 novel immunotherapeutic 69 Microplasmin 69 selective kinase inhibitor 69 HCV protease inhibitor 69 Interferon alfa 69 Bicifadine 69 A3 adenosine receptor 69 Romidepsin 69 Alfacell proprietary ribonuclease 69 Liprotamase 69 Leukine ® 69 ZFP Therapeutic 69 PKC# 69 Novolimus 69 Alocrest 69 Ozarelix 69 PORxin TM 69 AAG geldanamycin analog 69 TNFerade TM 69 Traficet EN 69 CCR9 antagonist 69 Initiates Enrollment 69 tubulin inhibitor 69 Trofex TM 69 IMiDs R 69 adenosine A2A 69 Enkephalin 69 HCV protease inhibitors 69 humanized monoclonal antibody 69 personalized immunotherapy 69 partial agonist 69 BEMA TM Fentanyl 69 RAV# 69 Elvitegravir 69 selective immunoproteasome inhibitor 69 demethylating agent 69 Curaxin CBLC# 69 vinca alkaloid 69 Symadex 69 CEQ# 69 Aganocide ® 69 Vascular Endothelial Growth 69 Alferon N 69 MAXY G# 69 epothilone 69 Recombinant Human 69 Fabry Disease 69 SGLT2 69 ACV1 69 Tesmilifene 69 FOLOTYN ® 69 HIV integrase inhibitors 69 eniluracil 69 Zorbtive TM 69 sterile lidocaine patch 69 Cathepsin S 69 Xcytrin R 69 PSN# [002] 69 Cx# [002] 69 Amrubicin 69 glucagon receptor 69 PANVAC VF 69 rNAPc2 69 Silodosin 69 CB2 selective receptor agonist 69 P#X# 69 Phase Ib study 69 Ceflatonin 69 plasmid DNA vaccine 69 HDL Mimetic Peptide 69 exon skipping 69 Irinotecan 69 OHR/AVR# 69 Varespladib 69 SinuNase ™ 69 Pertuzumab 69 HER1 69 chimeric monoclonal antibody 69 HCV polymerase 69 INCB# [001] 69 Fx #A 69 Enzyme Replacement Therapy 69 dextromethorphan quinidine 69 benign prostatic hypertrophy BPH 69 RhuDex 69 Pafuramidine 69 malignant ascites 69 Phase 2b Clinical Trial 69 Prodarsan R 69 Aplidin 69 pertuzumab 69 HCD# [002] 69 erlotinib Tarceva ® 69 Chemokine Receptor 69 Trabectedin 69 kallikrein 69 Anavex #-# 69 cartilage regeneration 69 outlicensed 69 CD# CEA 69 oncolytic virus therapies 69 soluble tumor necrosis 69 atacicept 69 Tasimelteon 69 peptidomimetic 69 Pazopanib 69 Campath ® 69 PI3K/mTOR 69 adult mesenchymal stem 69 delta isoform 69 SinuNase TM 69 Intravesical 69 Troxatyl 69 intravenous recombinant 68 monoclonal antibody MAb 68 nephropathic cystinosis 68 Therapeutic Vaccine 68 epigenetic therapies 68 dexpramipexole 68 Dacogen decitabine 68 MYDICAR ® 68 antisense drug 68 Ridaforolimus 68 essential thrombocythemia ET 68 LymphoStat B TM 68 cyclin dependent kinase inhibitor 68 ADAMTS# 68 Pradefovir 68 uricase 68 Bezielle 68 microtubule inhibitor 68 Gleevec resistant 68 BRAF inhibitor 68 incyclinide 68 Prolastin A1PI 68 sodium thiosulfate STS 68 Ad5FGF 4 68 MGd 68 TRX1 68 FLT3 68 Luteinizing Hormone Releasing Hormone 68 TLK# 68 sodium glucose cotransporter 68 XmAb# 68 bardoxolone 68 ONCONASE R 68 irreversible inhibitor 68 JAK2 inhibitors 68 sorafenib Nexavar 68 pro angiogenic 68 Tezampanel 68 GLP toxicology studies 68 CBLC# 68 stable nucleic acid 68 CD# antibody [001] 68 Aganocide 68 PI3K inhibitor 68 Vitaxin 68 octreotide acetate 68 VNP#M 68 PSN# [001] 68 HepDirect technology 68 EndoTAG TM -1 68 Inosine 68 CRTH2 68 highly selective inhibitor 68 Tacrolimus 68 selective estrogen receptor modulator 68 CRLX# 68 LEUKINE 68 Akt inhibitor 68 Sym# 68 TELINTRA 68 telomerase therapeutic 68 Clolar ® 68 Novel Oral 68 DPX Survivac 68 potent antiproliferative 68 Shigamabs ® 68 metastatic malignant 68 Tß4 68 Epidermal Growth Factor Receptor 68 Lisofylline 68 CCR2 68 HuMax CD4 68 Carfilzomib 68 Initiates Phase II 68 non porcine pancreatic 68 Thiarabine 68 orally dosed 68 neuroprotectant 68 muscarinic 68 Vivecon 68 PGL# 68 Talabostat 68 SomatoKine 68 bortezomib Velcade 68 alemtuzumab MS 68 anticancer therapeutics 68 VitiGam 68 immunomodulatory therapy 68 HepaSphere 68 non nucleoside 68 R#/MEM # 68 receptor antagonists 68 AKT inhibitor 68 Ganciclovir 68 Ceflatonin R 68 Vicriviroc 68 DURIN TM 68 Soliris eculizumab 68 Antiangiogenic 68 Cetrorelix 68 VAPRISOL 68 receptor blocker 68 OncoVEX 68 Bortezomib 68 Urokinase 68 Eluting Stent 68 multitargeted 68 anti CD# antibodies 68 huN# DM1 68 cangrelor 68 antibody MT# 68 Pancreate 68 BAY #-# 68 Protein Kinase C 68 Tyrima 68 Aerosurf 68 rFactor XIII 68 polymerase inhibitors 68 PLK1 SNALP 68 CD3 monoclonal antibody 68 cilengitide 68 selective agonist 68 MyVax R 68 Phase 2a clinical trials 68 Phase 2b Trial 68 thetreatment 68 Cintredekin Besudotox 68 mu opioid receptor antagonist 68 Desmoteplase 68 Zybrestat 68 acetylcholinesterase AChE 68 Firazyr 68 ZFP Therapeutics 68 GRNVAC1 68 topically administered 68 chemokine receptor 68 acyclovir Lauriad ® 68 CCR9 68 Plicera 68 Janus kinase 68 RELOVAIR ™ 68 HuMax 68 Lenalidomide 68 metastatic colorectal 68 BAL# [002] 68 Interferon Alpha 68 Fodosine 68 CMV vaccine 68 Iluvien TM 68 romazarit 68 CRMD# 68 SNT MC# 68 pharmacokinetic PK study 68 OvaRex ® MAb 68 gemcitabine Gemzar 68 Temsirolimus 68 cortisol synthesis 68 TG# [003] 68 Angiotensin Converting Enzyme 68 ATL/TV# 68 Phase 2a Clinical Trial 68 tyrosine kinase inhibitor 68 Homspera TM 68 HuMax CD# 68 neuronal nicotinic receptor NNR 68 selective orally bioavailable 68 Lubiprostone 68 oral antiviral 68 immunostimulatory 68 Surfaxin LS 68 PI3K/Akt pathway inhibitor 68 injectable formulation 68 multikinase inhibitor 68 acyclovir Lauriad R 68 Debio 68 wilate ® 68 myelofibrosis polycythemia vera 68 Nipent R 68 recombinant Factor 68 engineered anticoagulant 68 trodusquemine 68 LEP ETU 68 Vicinium TM 68 daptomycin 68 EZN 68 JAK2 Inhibitor 68 TNF Tumor Necrosis Factor 68 Blinatumomab 68 MAXY VII 68 PROSTVAC VF 68 KSP inhibitor 68 Elagolix 68 OXi# 68 taxane derivative 68 PXD# 68 teriflunomide 68 Hemospan 68 mitogen activated ERK kinase 68 OMP #M# 68 Tumor Necrosis Factor 68 Glufosfamide 68 nalbuphine ER 68 Cethrin R 68 Vidofludimus 68 glucokinase activator 68 Neuvenge 68 Drug Candidate 68 systemic immunosuppressive drugs 68 investigational therapies 68 aerosolized KL4 surfactant 68 Diabetic Neuropathy 68 oncolytic 68 Phase 1a clinical 68 MyVax ® 68 phase IIa clinical 68 hyaluronidase enzyme 68 ARRY # 68 RH1 68 CCR1 67 torezolid 67 AMPA kainate 67 nucleotide analog 67 thymosin beta 4 67 Apoptone 67 cholesteryl ester transfer 67 aldehyde dehydrogenase ALDH2 deficiency 67 anti angiogenic agent 67 ARG# 67 alpha#beta# integrin 67 small molecule chemotherapeutic 67 subcutaneous formulation 67 TOCOSOL 67 inhaled formulation 67 ARC# [002] 67 Zenvia ™ 67 anticancer compound 67 LymphoStat B belimumab 67 hereditary emphysema 67 Kepivance 67 enkephalin 67 oncolytic virus 67 acute peripheral arterial 67 HepaGam B 67 Myelodysplastic Syndrome MDS 67 Bafetinib 67 DDP# 67 antibody fragment 67 tafamidis 67 Indaflex TM 67 Pralatrexate 67 Allovectin 7 67 Icatibant 67 ALN TTR# 67 VEGF inhibitors 67 Amplimexon 67 AMPK activators 67 GV# [001] 67 vivo potency 67 Denufosol 67 XP# XP# 67 DNA intercalator 67 treat chronic sinusitis 67 docetaxel Taxotere ® 67 gemcitabine Gemzar ® 67 Simulect 67 Aurora kinase 67 Insegia 67 Initiates Clinical Trial 67 Prodrug 67 E1 INT TM 67 TRANSDUR Bupivacaine 67 otelixizumab 67 Tarvacin TM 67 immunotherapeutic agent 67 cediranib 67 TH# [003] 67 Bucindolol 67 inhibitor RG# 67 Vascular Wrap TM 67 Angiolix 67 sd rxRNA 67 gamma secretase inhibitor 67 Nexavar sorafenib 67 ibudilast 67 KRN# 67 CCR5 mAb 67 recombinant Factor VIIa 67 AQ4N 67 midstage clinical 67 bosutinib 67 Angiotensin 67 small molecule activator 67 KL4 surfactant 67 riociguat 67 FK# 67 reversible inhibitor 67 anticancer agent 67 Litx 67 ProMune 67 ALN TTR 67 docetaxel Taxotere R 67 EGS# 67 Unit Dose Budesonide 67 PAOD 67 pregabalin Lyrica 67 Febuxostat 67 Patients Treated With 67 Rebif ® 67 factor Xa 67 REG1 67 Pegloticase 67 Collategene 67 Anti VEGF 67 Ramoplanin 67 Alzhemed TM 67 Glypromate 67 ularitide 67 visilizumab 67 GA GCB 67 AVI NEUGENE 67 small molecule thrombopoietin 67 Saforis 67 entinostat 67 thrombopoietin TPO 67 PEP# [003] 67 Phase III Clinical Trial 67 mTOR mammalian target 67 Cardio Vascu Grow 67 investigational antiplatelet agent 67 virosome 67 LHRH antagonist 67 Corgentin 67 Generx ™ 67 BiTE 67 AMD# [003] 67 Golimumab 67 Files IND 67 Nuvion 67 methylnaltrexone bromide 67 PrevOnco 67 immatics 67 MCSP respectively 67 TÎ ² 4 67 OncoGel 67 triphendiol 67 Synavive 67 CCR5 antagonist 67 LibiGel ® 67 Trophos 67 alemtuzumab Campath 67 Vidaza azacitidine 67 annexin 67 RECOTHROM ® 67 arterial thrombosis 67 Plasmin 67 nilotinib Tasigna 67 miconazole Lauriad ® 67 Replacement Therapy 67 2 methoxyestradiol 67 Cimzia TM 67 PF # [002] 67 Bazedoxifene 67 recombinant plasma 67 NovaBay Aganocide compounds 67 MOVIPREP R 67 metastatic neuroendocrine tumors 67 Phase IIb Trial 67 acadesine 67 investigational hepatitis C 67 oral Janus kinase 67 HGS# 67 idiopathic thrombocytopenic purpura ITP 67 MAb 67 Pharmacokinetics PK 67 Triapine 67 neurotrophic 67 Exherin TM 67 interleukin IL -# 67 antitumoral 67 von Willebrand Factor 67 cidofovir 67 PEGylated anti 67 Prodarsan ® 67 vascular disrupting agent 67 dextofisopam 67 Iloperidone 67 BiovaxID TM 67 delta opioid receptor 67 murine monoclonal antibody 67 Octreolin 67 Inhaled nitric oxide 67 Atrasentan 67 antisense oligonucleotides 67 Technosphere ® 67 IgG1 monoclonal antibody 67 mGluR2 positive 67 GGF2 67 drug zotarolimus 67 siRNA therapeutics 67 beta interferons 67 Exherin 67 MET VEGFR2 67 Lenocta TM 67 CytoFabTM 67 alvespimycin 67 HDACi 67 Prolongs Survival 67 MYCAMINE 67 multiple myeloma MM 67 SUTENT ® 67 generation antisense 67 oral nucleoside analogue 67 Fibrinogen 67 Dyloject TM 67 Vernakalant 67 SAR# [002] 67 noninfectious uveitis 67 NeoLipid R 67 novel oral anticoagulant 67 novel therapeutic antibodies 67 Lysteda 67 HyACT 67 antisense oligonucleotide 67 Alfimeprase 67 Bosutinib 67 immune stimulatory 67 Spiegelmer ® 67 PSMA ADC 67 HyperAcute 67 mTOR inhibitors 67 HCV polymerase inhibitor 67 Allovectin 7 R 67 VA# [002] 67 CAMPATH 67 hypereosinophilic syndrome 67 Pemetrexed 67 anti infective treatments 67 C1INH 67 oral JAK1 67 Ambrisentan 67 XL# anticancer compounds 67 budesonide foam 67 HepDirect 67 gastrin 67 biologic therapeutics 67 GALNS 67 Sphingomab 67 Iluvien ® 67 multicenter Phase II 67 Argatroban 67 Potelligent Technology 67 Campath alemtuzumab 67 pathophysiological effects 67 NeoLipid TM 67 Resten MP 67 BCR ABL inhibitor 67 ulimorelin 67 deferiprone 67 mediated inhibition 67 IMC #B 67 orally inhaled 67 Delafloxacin 67 small molecule agonists 67 relapsed leukemia 67 Completes Patient Enrollment 67 Tarceva TM 67 Tyrosine Kinase Inhibitor 67 Methylnaltrexone 67 Cannabinor 67 preclinically 67 enzastaurin 67 Natalizumab 67 adalimumab Humira 67 Systemic Delivery 67 CINTREDEKIN BESUDOTOX 67 Eculizumab 67 PDGF receptor 67 Locked Nucleic Acid LNA 67 recombinant adeno associated 67 Onalta TM 67 factor Xa inhibitor 67 Myolimus 67 Bendamustine 67 Bicalutamide 67 Vaprisol 67 Prolastin C 67 SGLT 67 histamine dihydrochloride 67 SMIP 67 investigational pan BCR 66 Bruton tyrosine kinase Btk 66 oral Factor Xa 66 Lenocta 66 MVA BN R 66 Aptamer 66 vorinostat 66 drug conjugate 66 Receives Orphan Drug Designation 66 antiangiogenic agent 66 MVA BN 66 Metastatic Melanoma 66 LNP formulations 66 ara C 66 peptide conjugated 66 rilonacept 66 Pivotal Phase III 66 PDE# 66 ON #.Na 66 class mGluR5 inhibitor 66 Phase 2b clinical trials 66 BENLYSTA ® 66 IMiDs ® compound 66 immunoregulation 66 Triolex 66 endothelin receptor 66 herpetic keratitis 66 mda 7 66 generation antisense inhibitor 66 resolvins 66 erythropoietic 66 rhMBL 66 Cethrin 66 antiplatelet agent 66 Olaparib 66 Hedgehog antagonist 66 ANG# 66 EVIZON TM 66 muscarinic receptor agonist 66 Anti Tumor 66 BrachySil ™ 66 ZEVALIN ® 66 trastuzumab Herceptin 66 Fludara ® 66 MNTX 66 Phase Ib clinical 66 dasatinib Sprycel ® 66 delivers fluocinolone acetonide FA 66 midstage trials 66 midstage studies 66 abacavir Ziagen 66 5 HT4 66 Ophthotech 66 immune modulatory 66 Antithrombin 66 darinaparsin ZIO 66 seliciclib CYC# 66 5 HT6 receptor 66 hormone LHRH antagonist 66 Belerofon 66 PD LID 66 CCX# B 66 R#/MEM 66 somatostatin analog 66 Dual Opioid TM 66 cytotoxic T lymphocyte 66 Reports Preclinical Data 66 velafermin 66 ATG Fresenius S 66 sJIA 66 Fibrillex TM 66 ganetespib 66 protein kinase inhibitor 66 Deforolimus 66 RhuDex TM 66 peptidic 66 Bendavia 66 novel synthetic peptide 66 Vandetanib 66 Gefitinib 66 RNAi Therapeutic 66 Polymerase Inhibitor 66 Adenoscan R 66 immunoconjugate 66 opioid receptor antagonist 66 Cloretazine R 66 SMT C# 66 Breast Cancer Assay 66 #beta HSD1 66 p# MAP kinase inhibitor 66 investigational monoclonal antibody 66 tolevamer 66 NS4A 66 EndoTAG TM 66 cutaneous T 66 therapeutic monoclonal antibodies 66 Locked Nucleic Acid 66 telaprevir VX 66 adrenergic regulation 66 therapeutic peptide 66 tiuxetan 66 renin inhibitor 66 ketolide antibiotic 66 candidate TNFerade biologic 66 Nektar proprietary 66 neuroprotective properties 66 BCR ABL inhibitors 66 lumiliximab 66 highly selective endothelin 66 micafungin 66 mimetics 66 LPA1 receptor 66 long acting muscarinic 66 HepeX B 66 Symphogen 66 immunotoxin